These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20084885)

  • 1. [Analysis on the adverse event following immunization (AEFI) after supplementary immunization activity of measles attenuated live vaccine in Sichuan province in 2007-2008].
    Wang J; Liu QL; Yang CM
    Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):219-22. PubMed ID: 20084885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].
    Ye Y; Wang CS; Ma YT; Lu MX; Zhang XX; Zhang YY; Guo WS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):466-71. PubMed ID: 23791064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.
    Shu M; Liu Q; Wang J; Ao R; Yang C; Fang G; Wan C; Guo W
    Vaccine; 2011 Apr; 29(18):3507-10. PubMed ID: 19909830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis on epidemiological characteristics of measles before and after measles vaccine supplement immunization activities in Changzhou municipal in 2007].
    Zhang Q; Zhang JT; Bian C
    Zhongguo Yi Miao He Mian Yi; 2010 Feb; 16(1):15-9. PubMed ID: 20450066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
    Zhang SJ; Xiao QY; Li FJ
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on the characteristics of suspected vaccine-related deaths in Fujian Province, 2012-2017].
    Xiao JX; Lin ZQ; Wu RH; Zhou Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):719-723. PubMed ID: 31288344
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-vaccinal adverse effects monitoring during national campaign of vaccination against measles in Côte d'Ivoire].
    Die-Kacou H; Yavo JC; Kakou KA; Kamagaté M; Balayssac E; Daubrey PT; Gboignon VM
    Bull Soc Pathol Exot; 2009 Feb; 102(1):21-5. PubMed ID: 19343916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
    De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
    Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on the surveillance of adverse events following immunization in China, 2007-2008].
    Wu WD; Liu DW; Wu BB
    Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):481-90, 538. PubMed ID: 20518320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
    Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
    BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and epidemiological effects and influence factors of primary immunization with current live attenuated measles vaccine (Hu191) among infants aged 6-15 months.
    Youwang Y; Ping W; Feng C
    Vaccine; 2001 Feb; 19(15-16):1998-2005. PubMed ID: 11228370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
    Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
    Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining high rates of measles immunization in Africa.
    Lessler J; Moss WJ; Lowther SA; Cummings DA
    Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.